Clinical studies found that proinflammatory factors such as interleukin-6 (IL-6) and C-reactive protein (CRP) were significantly higher for the population who developed diagnosed diabetes over the follow-up period, and to some degree, these indicators could be used as powerful predictors of T2D [5, 6]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.